BerGenBio AS (BRRGF)

BerGenBio AS (BRRGF) Financial Statements


BerGenBio AS Financial Overview

BerGenBio AS's market cap is currently ―. The company's EPS TTM is $-0.033; its P/E ratio is -2.49; BerGenBio AS is scheduled to report earnings on February 14, 2024, and the estimated EPS forecast is
gt;-0.01. See an overview of income statement, balance sheet, and cash flow financials.
Mar 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue$ 66.54M$ 55.34M$ 0.00$ 0.00$ 0.00
Ebit$ 20.87M$ 20.31M$ -56.01M$ -82.27M$ -78.16M
Ebitda$ 24.20M$ 28.64M$ -55.87M$ -81.95M$ -77.85M
Net Income Common Stockholders$ 16.27M$ 47.12M$ -59.80M$ -84.07M$ -81.07M
Balance Sheet-
Total Assets$ 8.02B$ 6.46B$ 235.52M$ 306.03M$ 380.60M
Total Debt$ 407.83M$ 278.37M$ 0.00$ 651.00K$ 796.00K
Net Debt$ -896.11M$ -646.66M$ -164.90M$ -224.00M$ -308.04M
Total Liabilities$ 7.12B$ 5.82B$ 70.62M$ 82.03M$ 72.56M
Stockholders Equity$ 896.40M$ 646.66M$ 164.90M$ 224.00M$ 308.04M
Cash Flow-
Free Cash Flow$ 4.35M$ 11.87M$ -65.83M$ -70.69M$ -74.20M
Operating Cash Flow$ 4.68M$ 21.63M$ -65.83M$ -70.69M$ -74.20M
Investing Cash Flow$ 289.88M$ -18.03M$ 778.00K$ 445.00K$ 85.00K
Financing Cash Flow$ -106.36M$ -22.13M$ 0.00$ -74.00K$ 2.98M
Currency in USD

BerGenBio AS Earnings and Revenue History

BerGenBio AS Debt to Assets

BerGenBio AS Cash Flow

BerGenBio AS Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis